NDC codes

379838 NDC codes with hospital pricing data in the network.

• NDC 00409913711 — LIDOCAINE (PF) 50 MG/5 ML (1 %) INTRAVENOUS SYRINGE (44 hospitals, 4,979–6,293 samples)
• NDC 09991270800 — LIDOCAINE HCL 10 MG/ML (1 %) INJECTION SOLUTION (23 hospitals, 4,979–6,293 samples)
• NDC 83090000510 — LIDOCAINE (PF) 20 MG/ML (2 %) INJECTION SOLUTION (23 hospitals, 4,979–6,293 samples)
• NDC 83090000501 — LIDOCAINE (PF) 20 MG/ML (2 %) INJECTION SOLUTION (23 hospitals, 4,979–6,293 samples)
• NDC 73177010430 — HYDROMORPHONE HCL 0.2 MG-ML IV SOLN (34 hospitals, 5,207–6,287 samples)
• NDC 68084-0075-21 — TRETINOIN (ANTINEOPLASTIC) 10 MG CAPSULE (57 hospitals, 6,094–6,283 samples)
• NDC 69374097930 — morphine 30 mg/30 mL Soln-IV PCA (70 hospitals, 5,364–6,282 samples)
• NDC 00409230516 — MIDAZOLAM (PF) 1 MG/ML INJECTION SOLUTION (144 hospitals, 1,762–6,271 samples)
• NDC 65219047410 — SODIUM CHLORIDE 0.9 % IR SOLN (IV FOR IRRIGATION USE) (27 hospitals, 6,179–6,269 samples)
• NDC 67457-0469-10 — oxaliplatin 50 mg / 10 mL SDV inj. (33 hospitals, 6,223–6,268 samples)
• NDC 60687071801 — DEXAMETHASONE 4 MG PO TAB (70 hospitals, 5,036–6,260 samples)
• NDC 70092161746 — EPINEPHRINE-DEXTROSE 100-5 MCG/10ML-% IV SOSY (160 hospitals, 4,991–6,260 samples)
• NDC 70860-0701-41 — KETOROLAC 30 MG/ML (1 ML) INJ SOLN (46 hospitals, 5,902–6,253 samples)
• NDC 00338979101 — SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION (NON-PVC) (49 hospitals, 6,148–6,238 samples)
• NDC 09991363700 — SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION (6 hospitals, 6,148–6,238 samples)
• NDC 23155060031 — MIDAZOLAM HCL 2 MG/2ML IJ SOLN (211 hospitals, 2,103–6,234 samples)
• NDC 05446060701 — L.E.T. GEL (26 hospitals, 5,358–6,222 samples)
• NDC 71449006811 — KETAMINE HCL 50 MG/5ML IJ SOSY (WRAPPED) (98 hospitals, 5,358–6,222 samples)
• NDC 70092113544 — LIDOCAINE-EPINEPHRINE-TETRACAINE TOPICAL GEL (87 hospitals, 5,358–6,222 samples)
• NDC 69374052930 — HYDROMORPHONE 0.2 MG/ML, 1 MG/ML VARIABLE DOSE (24 hospitals, 5,358–6,222 samples)
• NDC 70092113644 — LIDOCAINE 4 %-RACEPINEPHRINE 0.05 %-TETRACAINE 0.5 % TOPICAL SOLUTION (27 hospitals, 5,358–6,222 samples)
• NDC 73702030115 — KETAMINE 50 MG/5 ML (10 MG/ML) IN 0.9 % SODIUM CHLORIDE IV SYRINGE (49 hospitals, 5,358–6,222 samples)
• NDC 70004081612 — Phenylephrine HCl-Sodium Chloride (30 hospitals, 5,358–6,222 samples)
• NDC 09991262300 — MITOMYCIN INTRAOCULAR INJ 0.4 MG/1 ML SYRINGE (23 hospitals, 5,358–6,222 samples)
• NDC 09991324001 — MAGNESIUM SULFATE 2 G IN 1000 ML 0.9% NACL PREMIX (23 hospitals, 5,358–6,222 samples)
• NDC 09991341700 — MITOMYCIN INTRAOCULAR INJ 0.2 MG/0.5 ML SYR (HPMC) (23 hospitals, 5,358–6,222 samples)
• NDC 71266903001 — PHENYLEPHRINE 0.8 MG/10 ML (80 MCG/ML) IN 0.9 %SOD.CHLORIDE IV SYRINGE (23 hospitals, 5,358–6,222 samples)
• NDC 09991202400 — DEXAMETHASONE 8 MG/50 ML IN 0.9 % SOD.CHLORIDE INTRAVENOUS PIGGYBACK (23 hospitals, 5,358–6,222 samples)
• NDC 09991283000 — HYDROXYCHLOROQUINE 25 MG/ML ORAL SUSPENSION (23 hospitals, 5,358–6,222 samples)
• NDC 09990971600 — NICARDIPINE 1 MG/10 ML IN 0.9 % SODIUM CHLORIDE INTRAVENOUS SYRINGE (23 hospitals, 5,358–6,222 samples)
• NDC 09991202700 — DEXAMETHASONE 20 MG/50 ML IN 0.9 % SOD. CHLORIDE INTRAVENOUS PIGGYBACK (23 hospitals, 5,358–6,222 samples)
• NDC 09991203200 — ONDANSETRON 16 MG/100 ML IN 0.9% SODIUM CHLORIDE INTRAVENOUS PIGGYBACK (23 hospitals, 5,358–6,222 samples)
• NDC 09991271400 — LIDOCAINE 4% (5 ML) + BUPIVACAINE 0.75% (5 ML) (23 hospitals, 5,358–6,222 samples)
• NDC 09990438000 — HYDROMORPHONE (PF) 30 MG/30 ML (1 MG/ML) IN 0.9 % NACL IV PCA SYRINGE (23 hospitals, 5,358–6,222 samples)
• NDC 09991262800 — VANCOMYCIN OPHTHALMIC SOLUTION 25 MG/ML (23 hospitals, 5,358–6,222 samples)
• NDC 09991287100 — GENTAMICIN 0.3 MG/ML SODIUM CITRATE 3 ML CATHETER DWELL (23 hospitals, 5,358–6,222 samples)
• NDC 09991322200 — KETAMINE 50 MG/5 ML (10 MG/ML) IN 0.9 % SODIUM CHLORIDE IV SYRINGE (23 hospitals, 5,358–6,222 samples)
• NDC 09991337400 — HYDROMORPHONE (PF) 10 MG/50 ML (0.2 MG/ML) IN 0.9% NACL IV PCA SYRINGE (23 hospitals, 5,358–6,222 samples)
• NDC 70092152049 — MORPHINE SULFATE 1 MG/ML IV SOLN (WRAPPER) (37 hospitals, 5,358–6,222 samples)
• NDC 09990961300 — LIDOCAINE 4 %-RACEPINEPHRINE 0.05 %-TETRACAINE 0.5 % TOPICAL GEL (23 hospitals, 5,358–6,222 samples)
• NDC 09990258200 — LIDOCAINE 4 %-RACEPINEPHRINE 0.05 %-TETRACAINE 0.5 % TOPICAL SOLUTION (23 hospitals, 5,358–6,222 samples)
• NDC 09991202500 — DEXAMETHASONE 10 MG/50 ML IN 0.9 % SOD.CHLORIDE INTRAVENOUS PIGGYBACK (23 hospitals, 5,358–6,222 samples)
• NDC 70004072509 — Lidocaine 1% Buffered Soln 5 mL (24 hospitals, 5,358–6,222 samples)
• NDC 09990437900 — HYDROMORPHONE (PF) 6 MG/30 ML (0.2 MG/ML) IN 0.9% NACL IV PCA SYRINGE (23 hospitals, 5,358–6,222 samples)
• NDC 09991271700 — PHENYLEPHRINE 0.8 MG/10 ML (80 MCG/ML) IN 0.9 %SOD.CHLORIDE IV SYRINGE (23 hospitals, 5,358–6,222 samples)
• NDC 09990694100 — LIDOCAINE 1 % BUFFERED WITH 8.4 % SODIUM BICARBONATE J-TIP INJ SYRINGE (NEO/PED) (23 hospitals, 5,358–6,222 samples)
• NDC 09991261900 — VORICONAZOLE INTRAOCULAR INJ 100 MCG/0.1 ML (23 hospitals, 5,358–6,222 samples)
• NDC 63323049157 — 63323-0491-57 - lidocaine 0.5 0.25 Soln (277 hospitals, 4,743–6,219 samples)
• NDC 63323049603 — LIDOCAINE HCL (PF) 2 INJECTION SOLN (WRAPPER) (50 hospitals, 4,981–6,214 samples)
• NDC 00409469954 — PROPOFOL 10 MG/ML INTRAVENOUS EMULSION (116 hospitals, 3,705–6,207 samples)